Suggest you put some of this granular detail directly to company given there is typically only some much time allocated to Q&A where high-level and near catalysts may be the focus points.
My understanding (that you'll need to verify for yourself directly with KCN):
6. Existing stockpile can go straight through process plant and before any proposed refurb (which is focused on increased throughput and process of fresh/oxide mix)
7. Chatree is less sensitive than most given it's Q1 on cost curve. There is naturally a sweet spot with most pit designs so anything around $1700 would likely see us easily double resource without blinking
8. Likely to include past proven employees looking for regular employment
9. Not much but perhaps things like setting-up the refinery to deal with increased volumes (they'll throw their own people in here to get this sorted), operational supplies, finalise hiring of full operation team etc
Note again I may have some of the above detail wrong so please be sure to get KCN to confirm.
- Forums
- ASX - By Stock
- KCN
- AGM Questions for Management
AGM Questions for Management, page-9
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KCN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.25 |
Change
-0.018(1.38%) |
Mkt cap ! $326.0M |
Open | High | Low | Value | Volume |
$1.30 | $1.30 | $1.25 | $709.9K | 553.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 73575 | $1.25 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.26 | 20911 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 73989 | 1.250 |
4 | 4366 | 1.245 |
4 | 27447 | 1.240 |
8 | 22763 | 1.235 |
6 | 32809 | 1.230 |
Price($) | Vol. | No. |
---|---|---|
1.255 | 20911 | 10 |
1.260 | 9651 | 8 |
1.265 | 5155 | 9 |
1.270 | 11993 | 6 |
1.275 | 21052 | 4 |
Last trade - 14.41pm 13/11/2024 (20 minute delay) ? |
Featured News
KCN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online